Table 3. Main procedure-related laboratory adverse events by CTCAE grades.
| CTCAE | pre-procedure | 3 months post-procedure | p value* | p value# | ||
|---|---|---|---|---|---|---|
| All grades | Grade≥3 | All grades | Grade≥3 | |||
| Leukocytopenia | 6(9.4) | 0 | 9(14.6) | 3(4.7) | 0.375 | 0.25 |
| HB | 5(7.8) | 0 | 3(4.7) | 0 | 0.5 | 1 |
| Thrombocytopenia | 19(29.7) | 0 | 27(42.2) | 3(4.7) | 0.077 | 0.25 |
| Hypoalbumin | 9(14.1) | 0 | 13(20.3) | 0 | 0.344 | 1 |
| ALT/AST↑ | 24(37.5) | 0 | 39(60.9) | 8(12.5) | 0.017 | 0.008 |
| TB↑ | 17(26.6) | 0 | 33(51.6) | 3(4.7) | 0.002 | 0.25 |
| GTT↑ | 36(56.3) | 0 | 39(60.9) | 17(26.6) | 0.664 | <0.001 |
| Creatinine | 0 | 0 | 2(3.1) | 0 | 0.5 | 1 |
| INR | 5(7.8) | 0 | 11(17.2) | 0 | 0.109 | 1 |
*: Intragroup differences in all grades LAEs between baseline and month 3 were analyzed with Exact McNemar's test, p<0.05 was considered statistically significant. #: Intragroup differences in grade≥3 LAEs between baseline and month 3 were also analyzed with Exact McNemar's test. TB: total bilirubin; ALT: alanine transaminase; AST: aspartate transaminase; INR: international normalized ratio; GGT: gamma-glutamyl transpeptidase; CTCAE: National Cancer Institute Common Terminology Criteria for Adverse Events.